Johannes Zuber is a Senior Group Leader at the Research Institute of Molecular Pathology (IMP) and an Adjunct Professor at the Medical University in Vienna, Austria. His lab develops and applies inducible loss-of-function genetic tools (iCas9, shRNAmir, ARTi, AID2), time-resolved transcriptomics, FACS-based and in-vivo screens to characterize regulatory pathways and dependencies in cancer and tumor-associated immune cells. He received several prestigious grants (e.g. ERC-StG 2013, EMBO-YIP 2014, ERC-POC 2019), has been awarded with the German Cancer Prize (“Deutscher Krebspreis”) in 2016, and named a Highly Cited Researcher in 2022 & 2025.